SEGLENTIS Drug Patent Profile
✉ Email this page to a colleague
When do Seglentis patents expire, and when can generic versions of Seglentis launch?
Seglentis is a drug marketed by Kowa Pharms and is included in one NDA. There are seven patents protecting this drug.
This drug has one hundred and five patent family members in thirty-five countries.
The generic ingredient in SEGLENTIS is celecoxib; tramadol hydrochloride. There are twenty-six drug master file entries for this compound. Additional details are available on the celecoxib; tramadol hydrochloride profile page.
DrugPatentWatch® Generic Entry Outlook for Seglentis
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be April 19, 2030. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SEGLENTIS?
- What are the global sales for SEGLENTIS?
- What is Average Wholesale Price for SEGLENTIS?
Summary for SEGLENTIS
International Patents: | 105 |
US Patents: | 7 |
Applicants: | 1 |
NDAs: | 1 |
Drug Prices: | Drug price information for SEGLENTIS |
What excipients (inactive ingredients) are in SEGLENTIS? | SEGLENTIS excipients list |
DailyMed Link: | SEGLENTIS at DailyMed |


DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for SEGLENTIS
Generic Entry Date for SEGLENTIS*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
US Patents and Regulatory Information for SEGLENTIS
SEGLENTIS is protected by seven US patents and one FDA Regulatory Exclusivity.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of SEGLENTIS is ⤷ Free Trial.
This potential generic entry date is based on patent 10,245,276.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | 10,238,668 | ⤷ Free Trial | Y | Y | ⤷ Free Trial | ||
Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | 8,598,152 | ⤷ Free Trial | Y | Y | ⤷ Free Trial | ||
Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | 8,846,744 | ⤷ Free Trial | Y | ⤷ Free Trial | |||
Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | ⤷ Free Trial | ⤷ Free Trial | ⤷ Free Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for SEGLENTIS
When does loss-of-exclusivity occur for SEGLENTIS?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
Argentina
Patent: 9008
Patent: CO-CRISTALES DE TRAMADOL Y COXIBS, PROCESO DE PREPARACION Y COMPOSICION FARMACEUTICA
Estimated Expiration: ⤷ Free Trial
Australia
Patent: 09304235
Patent: Co-crystals of tramadol and NSAIDs
Estimated Expiration: ⤷ Free Trial
Patent: 10306168
Patent: Co-crystals of tramadol and coxibs
Estimated Expiration: ⤷ Free Trial
Brazil
Patent: 0920358
Patent: cocristais de tramadol e insaids
Estimated Expiration: ⤷ Free Trial
Patent: 2012005011
Patent: cocristais de tramadol e coxibis
Estimated Expiration: ⤷ Free Trial
Canada
Patent: 37754
Patent: CO-CRISTAUX DE TRAMADOL ET D'AINS (CO-CRYSTALS OF TRAMADOL AND NSAIDS)
Estimated Expiration: ⤷ Free Trial
Patent: 71665
Patent: CO-CRISTAUX DE TRAMADOL ET DE COXIBS (CO-CRYSTALS OF TRAMADOL AND COXIBS)
Estimated Expiration: ⤷ Free Trial
China
Patent: 2186465
Patent: Co-crystals of tramadol and nsaids
Estimated Expiration: ⤷ Free Trial
Patent: 2573825
Patent: Co-crystals of tramadol and coxibs
Estimated Expiration: ⤷ Free Trial
Patent: 4817501
Patent: CO-CRYSTALS OF TRAMADOL AND COXIBS
Estimated Expiration: ⤷ Free Trial
Patent: 4844513
Patent: Co-crystals of tramadol and coxibs
Estimated Expiration: ⤷ Free Trial
Colombia
Patent: 11248
Patent: COCRISTALES DE TRAMADOL Y COXIBS
Estimated Expiration: ⤷ Free Trial
Croatia
Patent: 0130316
Estimated Expiration: ⤷ Free Trial
Patent: 0161526
Estimated Expiration: ⤷ Free Trial
Cyprus
Patent: 13956
Estimated Expiration: ⤷ Free Trial
Patent: 18374
Estimated Expiration: ⤷ Free Trial
Denmark
Patent: 49238
Estimated Expiration: ⤷ Free Trial
Patent: 88169
Estimated Expiration: ⤷ Free Trial
Ecuador
Patent: 12011734
Patent: COCRISTALES DE TRAMADOL Y COXIBS
Estimated Expiration: ⤷ Free Trial
European Patent Office
Patent: 77215
Patent: Co-cristaux de tramadol et NSAID (Co-crystals of tramadol and NSAIDs)
Estimated Expiration: ⤷ Free Trial
Patent: 49238
Patent: CO-CRISTAUX DE TRAMADOL ET NSAID (CO-CRYSTALS OF TRAMADOL AND NSAIDS)
Estimated Expiration: ⤷ Free Trial
Patent: 88169
Patent: CO-CRISTAUX DE TRAMADOL ET NSAID (CO-CRYSTALS OF TRAMADOL AND COXIBS)
Estimated Expiration: ⤷ Free Trial
Patent: 86432
Patent: Co-cristaux de Tramadol et NSAID tels que des Coxibs (Co-crystals of Tramadol and NSAIDs like Coxibs)
Estimated Expiration: ⤷ Free Trial
Hong Kong
Patent: 73380
Patent: CO-CRYSTALS OF TRAMADOL AND COXIBS
Estimated Expiration: ⤷ Free Trial
Hungary
Patent: 30976
Estimated Expiration: ⤷ Free Trial
India
Patent: 35DEN2012
Estimated Expiration: ⤷ Free Trial
Israel
Patent: 1785
Patent: קו-גבישים של טרמדול ונפרוקסן (Co-crystals of tramadol and naproxen)
Estimated Expiration: ⤷ Free Trial
Patent: 8256
Patent: קו-גביש של טרמדול הידרוכלוריד רצמי וסלקוקסיב (Co-crystal of (rac) tramadol hcl and celecoxib)
Estimated Expiration: ⤷ Free Trial
Japan
Patent: 99564
Estimated Expiration: ⤷ Free Trial
Patent: 45830
Estimated Expiration: ⤷ Free Trial
Patent: 12505847
Estimated Expiration: ⤷ Free Trial
Patent: 13507402
Estimated Expiration: ⤷ Free Trial
Lithuania
Patent: 49238
Estimated Expiration: ⤷ Free Trial
Malaysia
Patent: 6285
Patent: CO-CRYSTALS OF TRAMADOL AND COXIBS
Estimated Expiration: ⤷ Free Trial
Mexico
Patent: 6318
Patent: CO-CRISTALES DE TRAMADOL Y NSAIDS. (CO-CRYSTALS OF TRAMADOL AND NSAIDS.)
Estimated Expiration: ⤷ Free Trial
Patent: 11003612
Patent: CO-CRISTALES DE TRAMADOL Y NSAIDS. (CO-CRYSTALS OF TRAMADOL AND NSAIDS.)
Estimated Expiration: ⤷ Free Trial
Patent: 12003050
Patent: CO-CRISTALES DE TRAMADOL Y COXIBS. (CO-CRYSTALS OF TRAMADOL AND COXIBS.)
Estimated Expiration: ⤷ Free Trial
Morocco
Patent: 742
Patent: بلورات متعددة ترامادول و كوكسيب
Estimated Expiration: ⤷ Free Trial
New Zealand
Patent: 1873
Patent: CO-CRYSTALS OF TRAMADOL AND NSAIDS
Estimated Expiration: ⤷ Free Trial
Patent: 8353
Patent: Co-crystals of tramadol and coxibs
Estimated Expiration: ⤷ Free Trial
Poland
Patent: 49238
Estimated Expiration: ⤷ Free Trial
Patent: 88169
Estimated Expiration: ⤷ Free Trial
Portugal
Patent: 49238
Estimated Expiration: ⤷ Free Trial
Patent: 88169
Estimated Expiration: ⤷ Free Trial
Russian Federation
Patent: 47830
Patent: СОКРИСТАЛЛЫ ТРАМАДОЛА И КОКСИБОВ (CO-CRYSTALS OF TRAMADOL AND COXIBS)
Estimated Expiration: ⤷ Free Trial
Patent: 99717
Patent: СОКРИСТАЛЛИЧЕСКИЕ ФОРМЫ ТРАМАДОЛА И NSAID (CO-CRYSTALLINE FORMS OF TRAMADOL AND NSAID)
Estimated Expiration: ⤷ Free Trial
Patent: 11119608
Patent: СОКРИСТАЛЛИЧЕСКИЕ ФОРМЫ ТРАМАДОЛА И NSAID
Estimated Expiration: ⤷ Free Trial
Patent: 12120088
Patent: СОКРИСТАЛЛЫ ТРАМАДОЛА И КОКСИБОВ
Estimated Expiration: ⤷ Free Trial
San Marino
Patent: 01300048
Patent: Cocristalli di tramadol e inibitori della cox-2
Estimated Expiration: ⤷ Free Trial
Patent: 01600439
Patent: CO-CRISTALLI DI TRAMADOLO E NSAID
Estimated Expiration: ⤷ Free Trial
Singapore
Patent: 8835
Patent: CO-CRYSTALS OF TRAMADOL AND COXIBS
Estimated Expiration: ⤷ Free Trial
Slovenia
Patent: 49238
Estimated Expiration: ⤷ Free Trial
Patent: 88169
Estimated Expiration: ⤷ Free Trial
South Africa
Patent: 1102762
Patent: CO-CRYSTALS OF TRAMADOL AND NSAIDs
Estimated Expiration: ⤷ Free Trial
Patent: 1201892
Patent: CO-CRYSTALS OF TRAMADOL AND COXIBS
Estimated Expiration: ⤷ Free Trial
South Korea
Patent: 1471585
Estimated Expiration: ⤷ Free Trial
Patent: 1679400
Estimated Expiration: ⤷ Free Trial
Patent: 110069860
Patent: CO-CRYSTALS OF TRAMADOL AND NSAIDS
Estimated Expiration: ⤷ Free Trial
Patent: 120099212
Patent: CO-CRYSTALS OF TRAMADOL AND COXIBS
Estimated Expiration: ⤷ Free Trial
Spain
Patent: 02112
Estimated Expiration: ⤷ Free Trial
Patent: 03962
Estimated Expiration: ⤷ Free Trial
Taiwan
Patent: 41630
Estimated Expiration: ⤷ Free Trial
Patent: 1116273
Patent: Co-crystals of tramadol and coxibs
Estimated Expiration: ⤷ Free Trial
Tunisia
Patent: 12000075
Patent: CO-CRYSTALS OF TRAMADOL AND COXIBS
Estimated Expiration: ⤷ Free Trial
Ukraine
Patent: 9534
Patent: СПІВКРИСТАЛИ ТРАМАДОЛУ І КОКСИБІВ (TRAMADOL AND COXIBES COCRYSTALLS)
Estimated Expiration: ⤷ Free Trial
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering SEGLENTIS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 2586432 | ⤷ Free Trial | |
Portugal | 2488169 | ⤷ Free Trial | |
China | 102573825 | Co-crystals of tramadol and coxibs | ⤷ Free Trial |
Poland | 2349238 | ⤷ Free Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for SEGLENTIS
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0731795 | 10075033 | Germany | ⤷ Free Trial | PRODUCT NAME: CELECOXIB; NAT. REGISTRATION NO/DATE: 48802.00.00 20000518; FIRST REGISTRATION: SE 14838 19991203 |
2488169 | C202330042 | Spain | ⤷ Free Trial | PRODUCT NAME: COCRISTAL DE TRAMADOL, OPCIONALMENTE EN FORMA DE UNA SAL FISIOLOGICAMENTE ACEPTABLE, Y CELECOXIB; NATIONAL AUTHORISATION NUMBER: 89051; DATE OF AUTHORISATION: 20230925; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 89051; DATE OF FIRST AUTHORISATION IN EEA: 20230925 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Market Dynamics and Financial Trajectory for SEGLENTIS
More… ↓